DK0806202T3 - Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer - Google Patents

Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer

Info

Publication number
DK0806202T3
DK0806202T3 DK97400990T DK97400990T DK0806202T3 DK 0806202 T3 DK0806202 T3 DK 0806202T3 DK 97400990 T DK97400990 T DK 97400990T DK 97400990 T DK97400990 T DK 97400990T DK 0806202 T3 DK0806202 T3 DK 0806202T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
controlled release
stabilized
active substances
composition based
Prior art date
Application number
DK97400990T
Other languages
Danish (da)
English (en)
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0806202T3 publication Critical patent/DK0806202T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK97400990T 1996-05-06 1997-05-02 Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer DK0806202T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (fr) 1996-05-06 1996-05-06 Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs

Publications (1)

Publication Number Publication Date
DK0806202T3 true DK0806202T3 (da) 2002-05-06

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97400990T DK0806202T3 (da) 1996-05-06 1997-05-02 Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer

Country Status (16)

Country Link
EP (1) EP0806202B1 (zh)
JP (1) JP3983339B2 (zh)
CN (1) CN1171270A (zh)
AT (1) ATE212543T1 (zh)
AU (1) AU720146B2 (zh)
CA (1) CA2204475C (zh)
DE (1) DE69710121T2 (zh)
DK (1) DK0806202T3 (zh)
ES (1) ES2170922T3 (zh)
FR (1) FR2748209B1 (zh)
HU (1) HU222045B1 (zh)
NO (1) NO318227B1 (zh)
NZ (1) NZ314740A (zh)
PL (1) PL190562B1 (zh)
PT (1) PT806202E (zh)
ZA (1) ZA973836B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (fr) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solides autoemulsionnables matricielles a action prolongee.
FR2782006B1 (fr) 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
PL1660047T3 (pl) 2003-08-13 2014-05-30 Biocon Ltd Formulacje dawek stałych mikrocząsteczek soli kwasów tłuszczowych do środków terapeutycznych
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
US8293270B2 (en) * 2005-10-26 2012-10-23 Banner Pharmacaps, Inc. Lipophilic vehicle-based dual controlled release matrix system
CN101360485B (zh) 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
DE69710121D1 (de) 2002-03-14
EP0806202B1 (fr) 2002-01-30
NO318227B1 (no) 2005-02-21
JP3983339B2 (ja) 2007-09-26
PT806202E (pt) 2002-06-28
HUP9700842A1 (hu) 1998-08-28
HU9700842D0 (en) 1997-06-30
ATE212543T1 (de) 2002-02-15
CN1171270A (zh) 1998-01-28
NO972068L (no) 1997-11-07
FR2748209A1 (fr) 1997-11-07
AU720146B2 (en) 2000-05-25
NO972068D0 (no) 1997-05-05
PL319808A1 (en) 1997-11-10
ZA973836B (en) 1997-12-02
CA2204475A1 (fr) 1997-11-06
FR2748209B1 (fr) 1998-06-05
DE69710121T2 (de) 2002-11-28
AU1999197A (en) 1997-11-13
JPH1045629A (ja) 1998-02-17
NZ314740A (en) 1998-11-25
HU222045B1 (hu) 2003-04-28
PL190562B1 (pl) 2005-12-30
EP0806202A1 (fr) 1997-11-12
CA2204475C (fr) 2002-12-03
ES2170922T3 (es) 2002-08-16

Similar Documents

Publication Publication Date Title
ZA9811799B (en) Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
ES2100874T3 (es) Soporte para muestras de perfume.
DK0643963T3 (da) Biologisk nedbrydelig indretning til indgivelse af virksomme stoffer
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
WO2004043201A3 (de) Spender zur kontrollierten freisetzung flüchtiger substanzen
ATE383165T1 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung, die wasserunlösliche komplexverbindungen enthalten
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ATE267007T1 (de) Pharmazeutische tablette geeignet zur wirkstofffreisetzung in aufeinanderfolgenden und vorherbestimmbaren zeiträumen
TR199800743A3 (tr) Ispençiyari uygulamaya mahsus devamli salivermeli polimer karisim matrisi.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
BR8901900A (pt) Sistema para liberacao de uma substancia ativa para a atmosfera,matrizes e processo para formacao de um reservatorio de liberacao de substancia ativa
IT8719064A0 (it) Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive.
NO981638L (no) Legemiddel- avgivelsesanordning for to eller flere aktive forbindelser
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DK0806202T3 (da) Farmaceutisk sammensætning på basis af stabiliserede, lipofile matricer til kontrolleret frigivelse af aktive stoffer
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
DE69600601T2 (de) Heterocyclische, aromatische Verbindungen, pharmazeutische und kosmetische Zusammensetzungen,die sie enthalten, und Verwendungen.
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
DE3873016T2 (de) Optisch aktive, delta-valerolacton-ring enthaltende verbindung und dieselbe enthaltende fluessigkristalline zusammensetzung.
ES1004915Y (es) Dispositivo para vaporizar sustancias termicamente vaporizables.
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
HUT54691A (en) Anti-parasitical, insecticide, acaricide and nematocide preparatives containing 13-alkyl-23-imino- and 13-halogenic-23-imino-11-f28249 derivatives and process for producing the active substances
WO2003049719A3 (de) Matrizes zur stabilisierung und kontrollierten freigabe von problemstoffen
ATE219665T1 (de) Dosisformen und deren verwendungen